The provinces of Eastern Cuba and Camagüey recently initiated an expanded intervention study with Jusvinza, which benefits patients with rheumatoid arthritis with moderate to severe activity.
This drug is a Cuban product designed for the treatment of autoimmune diseases and will be administered to the patients who are part of the study for six months; during the first month of treatment, four vaccines will be given, at the rate of one weekly and then one monthly for the remaining five months.
According to the head of this study in Holguin, Dr. Alberto Alberteris Rodriguez, “after an evaluation of the cases, carried out in April of this year, the patients who were candidates to participate in the intervention study were selected.
They underwent the corresponding complementary examinations and after verifying that they met the inclusion criteria, the product was applied to them on the ninth of April. They had to remain under medical observation for three hours, as required by the protocol”.
Rheumatoid arthritis is a chronic inflammatory disease in which the immune system attacks its own tissues, among which are the joints, including those of the hands and feet.
Jusvinza is a Cuban biotechnological product made up of a molecule of 27 amino acids with an anti-inflammatory and immune response modulator effect.
Jusvinza, Holguín
Patients receiving the Cuban biotechnological product at the Lucía Hospital. Photo: Courtesy of Dr. Alberto Alberteris.At present, this product is in phase three of a clinical trial in Havana, while in the eastern part of the country and Camagüey, this expanded intervention study is being developed under the name of Mariana, in honor of Mariana Grajales, the Mother of the Homeland and because rheumatoid arthritis is a predominantly female disease, said the head of the Rheumatology Service at the Lucía Hospital.
In addition to rheumatoid arthritis, Jusvinza has previously been used for the treatment of COVID-19 in patients with hyperinflammation, and at the same time it is being used for conditions such as community pneumonia.
- Holguin Present at the 5th UNIANDES Scientific Congress - 25 de April de 2025
- Polio Vaccination Campaign to Immunize Children in Holguin - 22 de April de 2025
- UCMHo Distinction for Education Awards to Lenin Professionals - 13 de April de 2025